Bank Of Montreal

Direxion Daily Small Cap Bull 3X ETF

SPDR S&P Retail ETF

ProShares UltraPro Dow30

ProShares UltraShort Bloomberg Natrl Gas

Guggenheim Solar ETF

Direxion Technology Bear 3X Shares

Materials Select Sector SPDR

ProShares Trust ProShares Short Bitcoin Strategy ETF

ProShares Bitcoin Strategy ETF

Direxion Daily Small Cap Bear 3X ETF

ProShares Ultra Bloomberg Natural Gas

Direxion Daily Technology Bull 3X ETF

ARK Innovation ETF

Direxion Dly S&P Oil&Gs Ex&Prd Br 3X ETF

Magal Security Systems Ltd.

Direxion Financial Bear 3X Shar

Direxion Daily Semicondct Bull 3X ETF

JELD-WEN Holding Inc. Common Stock

Las Vegas Sands Corp. Common Stock

Century Communities Inc. Common Stock

Kontoor Brands Inc. Common Stock

Bath & Body Works Inc.

RLJ Lodging Trust Common Shares of Beneficial Interest $0.01 par value

Leggett & Platt Incorporated Common Stock

Snap Inc. Class A Common Stock

Cleveland-Cliffs Inc. Common Stock

Civitas Resources Inc. Common Stock

Archer Aviation Inc. Class A Common Stock

AMC Entertainment Holdings Inc. Class A Common Stock

Oklo Inc.

QuantumScape Corporation Class A Common Stock

Sea Limited American Depositary Shares each representing one Class A Ordinary Share

Cameco Corporation Common Stock

Twilio Inc. Class A Common Stock

Spotify Technology S.A. Ordinary Shares

Cloudflare Inc. Class A Common Stock

Molina Healthcare Inc Common Stock

Click here to get full coverage on Viking stock among gainers post Altimmune’s MASH data (MDGL) - Seeking Alpha

Viking stock among gainers post Altimmune’s MASH data (MDGL)  Seeking Alpha

Viking stock among gainers post Altimmune’s MASH data (MDGL) - Seeking Alpha

Click here to get full coverage on Madrigal Pharmaceuticals Inc (MDGL) Q1 2025 Earnings Call Highlights: Strong Sales Growth and ... - Yahoo Finance

Madrigal Pharmaceuticals Inc (MDGL) Q1 2025 Earnings Call Highlights: Strong Sales Growth and ...  Yahoo Finance

Madrigal Pharmaceuticals Inc (MDGL) Q1 2025 Earnings Call Highlights: Strong Sales Growth and ... - Yahoo Finance

Click here to get full coverage on Madrigal Pharmaceuticals (MDGL) Sees Stock Surge After Competito - GuruFocus

Madrigal Pharmaceuticals (MDGL) Sees Stock Surge After Competito  GuruFocus

Madrigal Pharmaceuticals (MDGL) Sees Stock Surge After Competito - GuruFocus

Click here to get full coverage on (MDGL) Proactive Strategies - news.stocktradersdaily.com

(MDGL) Proactive Strategies  news.stocktradersdaily.com

(MDGL) Proactive Strategies - news.stocktradersdaily.com

Click here to get full coverage on Breakthrough MASH Treatment Nears EU Approval: CHMP Backs First-Ever Therapy for Growing Liver Crisis - Stock Titan

Breakthrough MASH Treatment Nears EU Approval: CHMP Backs First-Ever Therapy for Growing Liver Crisis  Stock Titan

Breakthrough MASH Treatment Nears EU Approval: CHMP Backs First-Ever Therapy for Growing Liver Crisis - Stock Titan

Click here to get full coverage on Analysts Expect Breakeven For Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Before Long - simplywall.st

Analysts Expect Breakeven For Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Before Long  simplywall.st

Analysts Expect Breakeven For Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Before Long - simplywall.st

Click here to get full coverage on Insider Sale: Senior VP of $MDGL Sells 175 Shares - Nasdaq

Insider Sale: Senior VP of $MDGL Sells 175 Shares  Nasdaq

Insider Sale: Senior VP of $MDGL Sells 175 Shares - Nasdaq

Click here to get full coverage on Madrigal Pharmaceuticals (MDGL): Among Billionaire John Paulson’s Stocks with Huge Upside Potential - Insider Monkey

Madrigal Pharmaceuticals (MDGL): Among Billionaire John Paulson’s Stocks with Huge Upside Potential  Insider Monkey

Madrigal Pharmaceuticals (MDGL): Among Billionaire John Paulson’s Stocks with Huge Upside Potential - Insider Monkey

Click here to get full coverage on Madrigal Pharmaceuticals Announces Company Founder Rebecca Taub, M.D. to Become Senior Scientific and Medical Advisor; David Soergel, M.D., Appointed Chief Medical Officer - GlobeNewswire

Madrigal Pharmaceuticals Announces Company Founder Rebecca Taub, M.D. to Become Senior Scientific and Medical Advisor; David Soergel, M.D., Appointed Chief Medical Officer  GlobeNewswire

Madrigal Pharmaceuticals Announces Company Founder Rebecca Taub, M.D. to Become Senior Scientific and Medical Advisor; David Soergel, M.D., Appointed Chief Medical Officer - GlobeNewswire

Click here to get full coverage on MDGL Stock Down 10% on Disappointing Preliminary Q4 Rezdiffra Sales - Yahoo Finance

MDGL Stock Down 10% on Disappointing Preliminary Q4 Rezdiffra Sales  Yahoo Finance

MDGL Stock Down 10% on Disappointing Preliminary Q4 Rezdiffra Sales - Yahoo Finance

Click here to get full coverage on Madrigal Pharmaceuticals: An Encouraging Start For Rezdiffra (NASDAQ:MDGL) - Seeking Alpha

Madrigal Pharmaceuticals: An Encouraging Start For Rezdiffra (NASDAQ:MDGL)  Seeking Alpha

Madrigal Pharmaceuticals: An Encouraging Start For Rezdiffra (NASDAQ:MDGL) - Seeking Alpha

Click here to get full coverage on (MDGL) Investment Analysis - news.stocktradersdaily.com

(MDGL) Investment Analysis  news.stocktradersdaily.com

(MDGL) Investment Analysis - news.stocktradersdaily.com

Click here to get full coverage on $MDGL stock is up 13% today. Here's what we see in our data. - Nasdaq

$MDGL stock is up 13% today. Here's what we see in our data.  Nasdaq

$MDGL stock is up 13% today. Here's what we see in our data. - Nasdaq

Click here to get full coverage on Madrigal Pharmaceuticals (MDGL) Gains EU Regulatory Support for Rezdiffra - GuruFocus

Madrigal Pharmaceuticals (MDGL) Gains EU Regulatory Support for Rezdiffra  GuruFocus

Madrigal Pharmaceuticals (MDGL) Gains EU Regulatory Support for Rezdiffra - GuruFocus

Click here to get full coverage on Is Madrigal Pharmaceuticals (MDGL) The Most Expensive Stock Insiders Are Dumping In March? - Yahoo Finance

Is Madrigal Pharmaceuticals (MDGL) The Most Expensive Stock Insiders Are Dumping In March?  Yahoo Finance

Is Madrigal Pharmaceuticals (MDGL) The Most Expensive Stock Insiders Are Dumping In March? - Yahoo Finance

Click here to get full coverage on In Search Of Tailwind, Sailing Doldrums With Madrigal Pharmaceuticals Stock (MDGL) - Seeking Alpha

In Search Of Tailwind, Sailing Doldrums With Madrigal Pharmaceuticals Stock (MDGL)  Seeking Alpha

In Search Of Tailwind, Sailing Doldrums With Madrigal Pharmaceuticals Stock (MDGL) - Seeking Alpha

Click here to get full coverage on Madrigal Pharmaceuticals: GLP-1s Inch Closer To MASH Market As REZDIFFRA Outperform (MDGL) - Seeking Alpha

Madrigal Pharmaceuticals: GLP-1s Inch Closer To MASH Market As REZDIFFRA Outperform (MDGL)  Seeking Alpha

Madrigal Pharmaceuticals: GLP-1s Inch Closer To MASH Market As REZDIFFRA Outperform (MDGL) - Seeking Alpha

Click here to get full coverage on Madrigal Pharmaceuticals Inc (MDGL) Q4 2024 Earnings Call Highlights: Strong Sales Growth and ... - Yahoo Finance

Madrigal Pharmaceuticals Inc (MDGL) Q4 2024 Earnings Call Highlights: Strong Sales Growth and ...  Yahoo Finance

Madrigal Pharmaceuticals Inc (MDGL) Q4 2024 Earnings Call Highlights: Strong Sales Growth and ... - Yahoo Finance

Click here to get full coverage on Fast Drug Launch For Madrigal Pharmaceuticals Brings Buyout Discussion (NASDAQ:MDGL) - Seeking Alpha

Fast Drug Launch For Madrigal Pharmaceuticals Brings Buyout Discussion (NASDAQ:MDGL)  Seeking Alpha

Fast Drug Launch For Madrigal Pharmaceuticals Brings Buyout Discussion (NASDAQ:MDGL) - Seeking Alpha

Click here to get full coverage on Why Is Madrigal Pharmaceuticals, Inc. (MDGL) Among the Worst Performing Biotech Stocks in 2024? - Yahoo Finance

Why Is Madrigal Pharmaceuticals, Inc. (MDGL) Among the Worst Performing Biotech Stocks in 2024?  Yahoo Finance

Why Is Madrigal Pharmaceuticals, Inc. (MDGL) Among the Worst Performing Biotech Stocks in 2024? - Yahoo Finance

Click here to get full coverage on First Week of MDGL June 20th Options Trading - Nasdaq

First Week of MDGL June 20th Options Trading  Nasdaq

First Week of MDGL June 20th Options Trading - Nasdaq

Click here to get full coverage on Madrigal Pharmaceuticals Q4 Earnings Review: Strong Quarter, Even Stronger Outlook (MDGL) - Seeking Alpha

Madrigal Pharmaceuticals Q4 Earnings Review: Strong Quarter, Even Stronger Outlook (MDGL)  Seeking Alpha

Madrigal Pharmaceuticals Q4 Earnings Review: Strong Quarter, Even Stronger Outlook (MDGL) - Seeking Alpha

Click here to get full coverage on Madrigal Pharmaceuticals (MDGL) Receives Increased Price Target from Analyst | MDGL Stock News - GuruFocus

Madrigal Pharmaceuticals (MDGL) Receives Increased Price Target from Analyst | MDGL Stock News  GuruFocus

Madrigal Pharmaceuticals (MDGL) Receives Increased Price Target from Analyst | MDGL Stock News - GuruFocus

Click here to get full coverage on Madrigal Pharmaceuticals to Participate in the 46th Annual Global Goldman Sachs Health Care Conference - GlobeNewswire

Madrigal Pharmaceuticals to Participate in the 46th Annual Global Goldman Sachs Health Care Conference  GlobeNewswire

Madrigal Pharmaceuticals to Participate in the 46th Annual Global Goldman Sachs Health Care Conference - GlobeNewswire

Click here to get full coverage on Madrigal Pharmaceuticals to Release First-Quarter 2025 Financial Results and Host Webcast on May 1, 2025 - GlobeNewswire

Madrigal Pharmaceuticals to Release First-Quarter 2025 Financial Results and Host Webcast on May 1, 2025  GlobeNewswire

Madrigal Pharmaceuticals to Release First-Quarter 2025 Financial Results and Host Webcast on May 1, 2025 - GlobeNewswire

Click here to get full coverage on Madrigal Q1 Earnings Beat, MASH Drug Sales Drive Top Line, Stock Up - TradingView

Madrigal Q1 Earnings Beat, MASH Drug Sales Drive Top Line, Stock Up  TradingView

Madrigal Q1 Earnings Beat, MASH Drug Sales Drive Top Line, Stock Up - TradingView

Click here to get full coverage on Madrigal Pharmaceuticals: Rezdiffra First-Mover Advantage Gains Traction (Upgrade) (MDGL) - Seeking Alpha

Madrigal Pharmaceuticals: Rezdiffra First-Mover Advantage Gains Traction (Upgrade) (MDGL)  Seeking Alpha

Madrigal Pharmaceuticals: Rezdiffra First-Mover Advantage Gains Traction (Upgrade) (MDGL) - Seeking Alpha

Click here to get full coverage on Madrigal to Present Late-Breaking Resmetirom Data in - GlobeNewswire

Madrigal to Present Late-Breaking Resmetirom Data in  GlobeNewswire

Madrigal to Present Late-Breaking Resmetirom Data in - GlobeNewswire

Click here to get full coverage on MDGL Stock Dips Amid Preliminary 2024 Results Release - GuruFocus

MDGL Stock Dips Amid Preliminary 2024 Results Release  GuruFocus

MDGL Stock Dips Amid Preliminary 2024 Results Release - GuruFocus

Click here to get full coverage on Madrigal Pharmaceuticals Rezdiffra Vies For Blockbuster Status In MASH - Seeking Alpha

Madrigal Pharmaceuticals Rezdiffra Vies For Blockbuster Status In MASH  Seeking Alpha

Madrigal Pharmaceuticals Rezdiffra Vies For Blockbuster Status In MASH - Seeking Alpha

Click here to get full coverage on Madrigal Pharmaceuticals Closer to EU Approval for First MASH Treatment, Rezdiffra - Insider Monkey

Madrigal Pharmaceuticals Closer to EU Approval for First MASH Treatment, Rezdiffra  Insider Monkey

Madrigal Pharmaceuticals Closer to EU Approval for First MASH Treatment, Rezdiffra - Insider Monkey

Click here to get full coverage on EU medicines regulator grants conditional authorisation for Madrigal's liver disease drug - TradingView

EU medicines regulator grants conditional authorisation for Madrigal's liver disease drug  TradingView

EU medicines regulator grants conditional authorisation for Madrigal's liver disease drug - TradingView

Click here to get full coverage on Madrigal Pharmaceuticals price target raised to $239 from $154 at BofA - Yahoo Finance

Madrigal Pharmaceuticals price target raised to $239 from $154 at BofA  Yahoo Finance

Madrigal Pharmaceuticals price target raised to $239 from $154 at BofA - Yahoo Finance

Click here to get full coverage on Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)  GlobeNewswire

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Click here to get full coverage on Rezdiffra Gains Traction In NASH As Madrigal Pharmaceuticals Targets European Expansion - Seeking Alpha

Rezdiffra Gains Traction In NASH As Madrigal Pharmaceuticals Targets European Expansion  Seeking Alpha

Rezdiffra Gains Traction In NASH As Madrigal Pharmaceuticals Targets European Expansion - Seeking Alpha

Click here to get full coverage on Madrigal Receives Positive CHMP Opinion for Resmetirom (Rezdiffra™) for the Treatment of MASH with Moderate to Advanced Liver Fibrosis | MDGL Stock News - GuruFocus

Madrigal Receives Positive CHMP Opinion for Resmetirom (Rezdiffra™) for the Treatment of MASH with Moderate to Advanced Liver Fibrosis | MDGL Stock News  GuruFocus

Madrigal Receives Positive CHMP Opinion for Resmetirom (Rezdiffra™) for the Treatment of MASH with Moderate to Advanced Liver Fibrosis | MDGL Stock News - GuruFocus

Click here to get full coverage on 13 Best Biotech Stocks To Invest In Now - Insider Monkey

13 Best Biotech Stocks To Invest In Now  Insider Monkey

13 Best Biotech Stocks To Invest In Now - Insider Monkey

Click here to get full coverage on Madrigal Pharmaceuticals gains amid takeover speculation - MSN

Madrigal Pharmaceuticals gains amid takeover speculation  MSN

Madrigal Pharmaceuticals gains amid takeover speculation - MSN

Click here to get full coverage on Notable Thursday Option Activity: CRSR, MDGL, CFLT - Nasdaq

Notable Thursday Option Activity: CRSR, MDGL, CFLT  Nasdaq

Notable Thursday Option Activity: CRSR, MDGL, CFLT - Nasdaq

Click here to get full coverage on Madrigal Q4 Earnings Beat, MASH Drug Sales Drive Top Line, Stock Up - Yahoo Finance

Madrigal Q4 Earnings Beat, MASH Drug Sales Drive Top Line, Stock Up  Yahoo Finance

Madrigal Q4 Earnings Beat, MASH Drug Sales Drive Top Line, Stock Up - Yahoo Finance

Click here to get full coverage on Madrigral Pharmaceuticals gains amid takeover speculation - MSN

Madrigral Pharmaceuticals gains amid takeover speculation  MSN

Madrigral Pharmaceuticals gains amid takeover speculation - MSN

Click here to get full coverage on Why Madrigal Pharmaceuticals Stock Is Soaring Today - The Motley Fool

Why Madrigal Pharmaceuticals Stock Is Soaring Today  The Motley Fool

Why Madrigal Pharmaceuticals Stock Is Soaring Today - The Motley Fool

Click here to get full coverage on Madrigal Pharmaceuticals Clears Technical Benchmark, Hitting 90-Plus RS Rating - Investor's Business Daily

Madrigal Pharmaceuticals Clears Technical Benchmark, Hitting 90-Plus RS Rating  Investor's Business Daily

Madrigal Pharmaceuticals Clears Technical Benchmark, Hitting 90-Plus RS Rating - Investor's Business Daily

Click here to get full coverage on Madrigal Pharmaceuticals Reports First-Quarter 2025 Financial Results and Provides Corporate Updates - GlobeNewswire

Madrigal Pharmaceuticals Reports First-Quarter 2025 Financial Results and Provides Corporate Updates  GlobeNewswire

Madrigal Pharmaceuticals Reports First-Quarter 2025 Financial Results and Provides Corporate Updates - GlobeNewswire

Click here to get full coverage on Why Madrigal Pharmaceuticals Stock Was Plummeting This Week - The Motley Fool

Why Madrigal Pharmaceuticals Stock Was Plummeting This Week  The Motley Fool

Why Madrigal Pharmaceuticals Stock Was Plummeting This Week - The Motley Fool

Click here to get full coverage on Madrigal CEO on Q4 earnings beat, MASH drug market opportunity - CNBC

Madrigal CEO on Q4 earnings beat, MASH drug market opportunity  CNBC

Madrigal CEO on Q4 earnings beat, MASH drug market opportunity - CNBC

Click here to get full coverage on Madrigal Pharma Short Interest Reaches 4-Month High: Retail Investors Still Bullish On Stock - Stocktwits

Madrigal Pharma Short Interest Reaches 4-Month High: Retail Investors Still Bullish On Stock  Stocktwits

Madrigal Pharma Short Interest Reaches 4-Month High: Retail Investors Still Bullish On Stock - Stocktwits

Click here to get full coverage on Madrigal Pharmaceuticals Holds 2025 Annual Stockholders Meeting - TipRanks

Madrigal Pharmaceuticals Holds 2025 Annual Stockholders Meeting  TipRanks

Madrigal Pharmaceuticals Holds 2025 Annual Stockholders Meeting - TipRanks

Click here to get full coverage on Citizens JMP reiterates Madrigal stock with $443 target - Investing.com

Citizens JMP reiterates Madrigal stock with $443 target  Investing.com

Citizens JMP reiterates Madrigal stock with $443 target - Investing.com

Click here to get full coverage on Why Madrigal Pharmaceuticals Stock Is Sinking Today - The Motley Fool

Why Madrigal Pharmaceuticals Stock Is Sinking Today  The Motley Fool

Why Madrigal Pharmaceuticals Stock Is Sinking Today - The Motley Fool

Click here to get full coverage on Billionaire John Paulson’s 10 Stocks with Huge Upside Potential - Insider Monkey

Billionaire John Paulson’s 10 Stocks with Huge Upside Potential  Insider Monkey

Billionaire John Paulson’s 10 Stocks with Huge Upside Potential - Insider Monkey

Click here to get full coverage on Earnings call transcript: Madrigal Pharmaceuticals beats Q1 2025 EPS forecasts - Investing.com

Earnings call transcript: Madrigal Pharmaceuticals beats Q1 2025 EPS forecasts  Investing.com

Earnings call transcript: Madrigal Pharmaceuticals beats Q1 2025 EPS forecasts - Investing.com

Click here to get full coverage on Madrigal Pharmaceuticals’ SWOT analysis: rezdiffra’s promise drives stock outlook - Investing.com

Madrigal Pharmaceuticals’ SWOT analysis: rezdiffra’s promise drives stock outlook  Investing.com

Madrigal Pharmaceuticals’ SWOT analysis: rezdiffra’s promise drives stock outlook - Investing.com

Click here to get full coverage on Madrigal Pharma earnings beat by $0.54, revenue topped estimates - Investing.com

Madrigal Pharma earnings beat by $0.54, revenue topped estimates  Investing.com

Madrigal Pharma earnings beat by $0.54, revenue topped estimates - Investing.com

Click here to get full coverage on Madrigal Pharmaceuticals stock jumps on MASH drug hopes - Yahoo Finance

Madrigal Pharmaceuticals stock jumps on MASH drug hopes  Yahoo Finance

Madrigal Pharmaceuticals Inc (MDGL)

Price Chart

Key Statistics

Technicals

About MDGL

Latest News

Viking stock among gainers post Altimmune’s MASH data (MDGL) - Seeking Alpha

Madrigal Pharmaceuticals Inc (MDGL) Q1 2025 Earnings Call Highlights: Strong Sales Growth and ... - Yahoo Finance

Madrigal Pharmaceuticals (MDGL) Sees Stock Surge After Competito - GuruFocus

Advanced Charts

Top Gainers

Top Losers